Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant drop in short interest in June. As of June 15th, there was short interest totaling 2,584 shares, a drop of 88.6% from the May 31st total of 22,688 shares. Based on an average trading volume of 98,688 shares, the short-interest ratio is presently 0.0 days.

Cardio Diagnostics Stock Performance

Shares of NASDAQ CDIOW remained flat at $0.02 during trading hours on Friday. Cardio Diagnostics has a 52 week low of $0.01 and a 52 week high of $0.07. The stock has a 50 day moving average of $0.02 and a 200-day moving average of $0.02.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.